NEW YORK (GenomeWeb) – Genomic Health reported after the close of the market Tuesday that its fourth quarter revenues rose 10 percent year over year, buoyed by an increase in its prostate cancer testing business and international test revenues.

For the three months ended Dec. 31, 2016, Genomic Health's total revenues rose to $82.7 million from $75.1 million in the same period last year. Wall street analysts had expected, on average, revenue of $84.1 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.